PTC Therapeutics Files Q1 2025 10-Q
Ticker: PTCT · Form: 10-Q · Filed: May 6, 2025 · CIK: 1070081
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
PTC Therapeutics filed their Q1 2025 10-Q, showing financial updates.
AI Summary
PTC Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and balance sheet items are presented, reflecting the company's ongoing activities in the pharmaceutical sector.
Why It Matters
This filing provides investors with the latest financial health and operational status of PTC Therapeutics, crucial for understanding their investment in the company.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, PTC Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 79,225,276 — Total Assets (As of March 31, 2025)
- 77,704,188 — Total Liabilities (As of March 31, 2025)
Key Players & Entities
- PTC Therapeutics, Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of the reporting period
- 20250506 (date) — Filing date
FAQ
What were PTC Therapeutics' total assets as of March 31, 2025?
PTC Therapeutics' total assets were $79,225,276 as of March 31, 2025.
What were PTC Therapeutics' total liabilities as of March 31, 2025?
PTC Therapeutics' total liabilities were $77,704,188 as of March 31, 2025.
What is the fiscal year end for PTC Therapeutics, Inc.?
The fiscal year end for PTC Therapeutics, Inc. is December 31.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on May 6, 2025.
What is the Standard Industrial Classification for PTC Therapeutics, Inc.?
The Standard Industrial Classification for PTC Therapeutics, Inc. is Pharmaceutical Preparations [2834].
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding PTC THERAPEUTICS, INC. (PTCT).